Insider trading · Q3 2026 · CIK 1709941

BioAge Labs, Inc. (BIOA) insider trading.

In Q3 2026, insiders at BioAge Labs, Inc. reported 10 non-derivative transactions on 1 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $1.6M.

Transactions
10
Purchases (P)
0
Sales (S)
2
Net shares, P minus S
-62,566
Insiders
1
Last filed
2026-07-01

Insiders

InsiderRelationshipTransactionsBuysSales
Barton ShaneOfficer · Principal Accounting Officer1002

Transactions

10 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-06-30Barton ShaneM (A)4,000$8.398,290Form 4
2026-06-30Barton ShaneM (A)4,065$4.312,355Form 4
2026-06-30Barton ShaneM (A)7,861$4.3820,216Form 4
2026-06-30Barton ShaneS (D)20,216$25.190Form 4
2026-06-30Barton ShaneM (A)4,290$10.854,290Form 4
2026-06-29Barton ShaneM (A)7,261$8.3919,194Form 4
2026-06-29Barton ShaneM (A)8,958$4.328,152Form 4
2026-06-29Barton ShaneM (A)14,198$4.3842,350Form 4
2026-06-29Barton ShaneS (D)42,350$25.210Form 4
2026-06-29Barton ShaneM (A)9,301$10.8511,933Form 4

Transaction codes in this quarter

Get BIOA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1709941&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · BIOA company page · BioAge Labs, Inc. on SEC.gov

Questions

Are insiders buying or selling BioAge Labs, Inc. (BIOA)?

In Q3 2026, insiders at BioAge Labs, Inc. reported 10 non-derivative transactions on 1 Forms 3, 4 and 5: 0 open-market purchases and 2 sales worth $1.6M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these BioAge Labs, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/bioa.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.